Arthur Levin

Director

Arthur Levin, PhD, is a Director at Marrow Therapeutics, bringing over 30 years of experience in drug development across all stages from research through regulatory approval and commercialization, with deep expertise in advancing complex biological medicines from early development to the clinic.

Throughout his career, he has held senior leadership positions at several pioneering biotechnology companies, including Avidity Biosciences, where he served as a founding member and Distinguished Scientist, as well as roles at miRagen Therapeutics, Ionis Pharmaceuticals and Santaris Pharma. Dr. Levin has led multiple programs utilizing oligonucleotide therapeutics, authored numerous peer-reviewed scientific publications, and is recognized as an expert in RNA-based therapeutics.

Dr. Levin holds a PhD in toxicology from the University of Rochester and a BA in biology from Muhlenberg College.